NT_1170x120_1-11-18

Paul Julian

Julian to retire from McKesson

SAN FRANCISCO — Paul Julian, executive vice president and group president at McKesson Corp., is slated to retire at the end of the year. Julian currently has senior operating responsibility for McKesson’s domestic and international Distribution Solutions businesses, including pharmaceutical distribution, medical-surgical distribution, specialty health and retail pharmacy systems and automation. As president of McKesson

McKesson leverages scale to deliver value

McKesson leverages scale to deliver value

Members of McKesson Corp.’s senior management know what it takes to be a major player in the global health care marketplace, and they are moving decisively to ensure that going forward the company remains a dominant force in the sector. McKesson in recent years has made a number of strategic acquisitions that deepen and extend

McKesson Canada names Domenic Pilla as CEO

TORONTO — Domenic Pilla has been appointed chief executive officer of McKesson Canada. Pilla now guides Canada’s largest distributor of pharmaceuticals and medical supplies and oversees the integration of Rexall Health, which McKesson Canada acquired in late ­December. McKesson Canada picked up about 470 retail pharmacies in the Rexall deal. Pilla reports to Paul Julian,

Domenic Pilla tabbed as McKesson Canada CEO

Domenic Pilla tabbed as McKesson Canada CEO

SAN FRANCISCO and TORONTO — McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. McKesson said late Wednesday that Pilla is slated to take the reins as McKesson Canada CEO on Jan. 3. In the role, he will

McKesson cleared to acquire Rexall

McKesson cleared to acquire Rexall

SAN FRANCISCO — McKesson Corp. has been given the green light from the Competition Bureau of Canada to finalize its $2.2 billion acquisition of drug chain Rexall Health. McKesson said Wednesday that under the consent agreement it signed with the bureau, it must sell a total of 26 Rexall drug stores in Alberta, British Columbia,

McKesson Canada taps Keays as president

MONTREAL — Sixteen-year company veteran Paula Keays has been promoted to president of McKesson Canada. Keays had been senior vice president of pharmaceutical distribution and operations. She fills the vacancy that was created by the late-summer departure of Alain Champagne, who joined sales training and development firm Optimé International as a partner and chief executive

McKesson Canada names new president

McKesson Canada names new president

ST. LAURENT, Quebec — McKesson Canada has promoted pharmaceutical distribution chief Paula Keays to president. Keays, senior vice president of pharmaceutical distribution and operations, takes the reins as president effective immediately, McKesson Canada said Monday. She fills the vacancy created by the late summer departure of Alain Champagne, who joined sales training and development firm Optimé

McKesson adds Rexall Health to Canadian holdings

McKesson adds Rexall Health to Canadian holdings

TORONTO — McKesson Corp.’s $2.2 billion deal to acquire Rexall Health from Katz Group will strengthen the drug distributor’s position in Canada’s pharmaceutical supply chain. McKesson said the agreement is a natural next step for two companies that have worked together for over 20 years. In 2012, McKesson bought Katz’s 1,100-store banner operation covering I.D.A.,

McKesson to acquire Rexall for $2.2 billion

McKesson to acquire Rexall for $2.2 billion

SAN FRANCISCO and TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $2.2 billion ($3 billion Canadian). McKesson said Wednesday that the deal will strengthen its position in Canada’s pharmaceutical supply chain and is a natural step for the two companies, which have worked together for more

McKesson agrees to acquire Rx distributor in Ireland

SAN FRANCISCO — McKesson Corp. has agreed to purchase the pharmaceutical distribution division of Dublin, Ireland-based UDG Healthcare PLC for about $466 million. The deal — which is contingent upon a vote of approval from UDG Healthcare shareholders and clearance from European Union regulators — would give McKesson distribution channels across the Republic of Ireland

McKesson to buy Ireland’s UDG Healthcare

McKesson to buy Ireland’s UDG Healthcare

SAN FRANCISCO — McKesson Corp. plans to acquire the pharmaceutical distribution division of Dublin, Ireland-based UDG Healthcare plc for about $466 million. McKesson said early Friday that under the deal it will purchase United Drug and United Drug Sangers, leading wholesale operations across the Republic of Ireland and Northern Ireland, respectively; TCP, a home health

HDMA honors McKesson’s Julian with Nexus Award

HDMA honors McKesson’s Julian with Nexus Award

ARLINGTON, Va. — McKesson Corp. executive Paul Julian has received the 2015 Nexus Award for Lifetime Achievement from the Healthcare Distribution Management Association’s Center for Healthcare Supply Chain Research and Genentech Inc. HDMA said Tuesday that Julian, executive vice president and group president at McKesson, was presented the award this week at the 2015 HDMA

McKesson taps Tyler to head Rx distribution

SAN FRANCISCO — Brian Tyler has been promoted to president of North American pharmaceutical distribution and services at McKesson Corp. The company also has hired Bansi Nagji to take over Tyler’s previous post as executive vice president of corporate strategy and business development. As president of North American pharmaceutical distribution, Tyler takes on a new